This presumption is supported by the finding that chemical inhibition of non-canonical NF-κB signaling using PBS-1086 (pan NF-κB inhibitor) did not impede corporate apoptosis induction of VCR and LCL161 in established and de novo neuroblastoma cell lines as well (Figure 3B and Supplementary Figure 1B). Here, NFKB1 is linked to neuroblastoma.